Breast cancer-associated protein - a novel binding partner of Mason-Pfizer monkey virus protease

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F14%3A00437907" target="_blank" >RIV/61388963:_____/14:00437907 - isvavai.cz</a>
Alternative codes found
RIV/60461373:22330/14:43897337
Result on the web
<a href="http://dx.doi.org/10.1099/vir.0.064345-0" target="_blank" >http://dx.doi.org/10.1099/vir.0.064345-0</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1099/vir.0.064345-0" target="_blank" >10.1099/vir.0.064345-0</a>

Result language
angličtina
Original language name
Breast cancer-associated protein - a novel binding partner of Mason-Pfizer monkey virus protease
Original language description
We identified breast cancer-associated protein (BCA3) as a novel binding partner of Mason-Pfizer monkey virus (MPMV) protease (PR). The interaction was confirmed by co-immunoprecipitation and immunocolocalization of MPMV PR and BCA3. Full-length but notC-terminally truncated BOA3 was incorporated into MPMV virions. We ruled out the potential role of the G-patch domain, a glycine-rich domain located at the C terminus of MPMV PR, in BCA3 interaction and virion incorporation. Expression of BCA3 did not affect MPMV particle release and proteolytic processing; however, it slightly increased MPMV infectivity.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EE - Microbiology, virology
OECD FORD branch
—

Project
<a href="/en/project/GA204%2F09%2F1388" target="_blank" >GA204/09/1388: Characterization of novel host cell protein interacting with protease of Mason-Pfizer monkey virus</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)